Cobalt-Directed Assembly of Antibodies onto Metal-Phenolic Networks for Enhanced Particle Targeting.


Journal

Nano letters
ISSN: 1530-6992
Titre abrégé: Nano Lett
Pays: United States
ID NLM: 101088070

Informations de publication

Date de publication:
08 04 2020
Historique:
pubmed: 11 3 2020
medline: 26 1 2021
entrez: 11 3 2020
Statut: ppublish

Résumé

The orientation-specific immobilization of antibodies onto nanoparticles, to preserve antibody-antigen recognition, is a key challenge in developing targeted nanomedicines. Herein, we report the targeting ability of metal-phenolic network (MPN)-coated gold nanoparticles with surface-physisorbed antibodies against respective antigens. The MPN coatings were self-assembled from metal ions (Fe

Identifiants

pubmed: 32155075
doi: 10.1021/acs.nanolett.0c00295
doi:

Substances chimiques

Antibodies, Immobilized 0
Cross-Linking Reagents 0
Fluorescent Dyes 0
Immunoglobulin G 0
Tannins 0
Cobalt 3G0H8C9362
Gold 7440-57-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2660-2666

Auteurs

Wenjie Zhang (W)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia.

Quinn A Besford (QA)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia.

Andrew J Christofferson (AJ)

School of Engineering, RMIT University, GPO Box 2476, Melbourne, Victoria 3001, Australia.

Patrick Charchar (P)

School of Engineering, RMIT University, GPO Box 2476, Melbourne, Victoria 3001, Australia.

Joseph J Richardson (JJ)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia.

Aaron Elbourne (A)

Nanobiotechnology Laboratory, School of Science, RMIT University, Melbourne Victoria 3001, Australia.

Kristian Kempe (K)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.

Christoph E Hagemeyer (CE)

NanoBiotechnology Laboratory, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria 3004, Australia.

Matthew R Field (MR)

RMIT Microscopy & Microanalysis Facility, RMIT University, Melbourne, Victoria 3001, Australia.

Chris F McConville (CF)

College of Science, Engineering and Health, RMIT University, GPO Box 2476, Melbourne, Victoria 3001, Australia.

Irene Yarovsky (I)

School of Engineering, RMIT University, GPO Box 2476, Melbourne, Victoria 3001, Australia.

Frank Caruso (F)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH